Company news
Cardax Inc news in 2018
Cardax Inc's news releases, calls and decks from 2018, newest first.
Cardax and GNC Announce Expanded ZanthoSyn® Sales and Marketing Program
December 3, 2018
Cardax Names Former Amarin Head of Development Paresh N. Soni, MD, PhD, to lead Clinical and Regulatory Strategy
November 28, 2018
Cardax Reports Q3 2018 Results
November 13, 2018
Cardax Launches Human Clinical Trial Targeting Cardiovascular Inflammatory Health
October 2, 2018
Cardax Reports Q2 2018 Results
August 13, 2018
Cardax Announces Successful Completion of Warrant Exchange Offer
July 30, 2018
Cardax Announces Extension of Warrant Exchange Offer to July 27, 2018
July 23, 2018
Cardax Announces Effectiveness of Registration Statement and Commencement of Warrant Exchange Offer
June 22, 2018
Cardax Engages Industry Veteran Fred Sancilio, Ph.D., to Launch Orphan Drug Development Program
June 13, 2018
Cardax Adds Makarand Jawadekar, Ph.D., and Elona Kogan to its Board of Directors
June 1, 2018
Cardax Reports Q1 2018 Results
May 9, 2018
Cardax Announces Warrant Exchange Offer
May 2, 2018
Cardax Reports 2017 Results
March 27, 2018
Cardax Inks Deal to Distribute ZanthoSyn® in China
February 17, 2018
Cardax's ZanthoSyn® is No. 1 Seller at GNC Hawaii Stores
February 17, 2018